Case study First-in-class drug discovery: de novo design and lead optimization solutions for data-sparse targetsAvammune develops novel oncology therapeutics using multi-modal approaches that target hard-to-treat cancers with distinct biological mechanisms....
Article Cresset launches Flare AI Client, enabling scientists to use company-approved AI providers directly within FlareScientists can now connect company-approved AI providers such as Claude Code and GitHub Copilot directly to Flare.
Article Flare™ V13 released: Discover better molecules faster with AI-powered new molecule generation and R-group exploration in 3DWe are excited to announce the release of Flare V13, which brings a powerful new set of AI tools to the platform plus enhancements to Relative FEP....
Article Reviewing the Crystal Structures of Ternary Complexes Formed by Heterobifunctional DegradersWe assess the biological relevance of deposited crystal structures of ternary Complexes formed by heterobifunctional degraders...
Blog ACS Fall 2026 in ChicagoFrom cutting-edge research to first disclosures, Stuart Lang shares a snapshot of current advancements from his attendance at ACS Fall in Chicago...
Poster Designing better molecules: leveraging in silico tools to drive smarter drug discovery decisions
Article Application of generative AI to design covalent inhibitors of prolyl oligopeptidaseGenerative chemistry is revolutionizing drug discovery, using AI to efficiently explore entirely new areas of chemical space in the search for...
Webinar What’s new in Flare™ V12: significant enhancements to FEP and structure-based methodsFind out what’s new in Flare V12 in our latest webinar
Article Flare™ V12 released: Significant improvements to FEP calculations and structure-based methodsWe are pleased to announce the release of Flare V12, which introduces a range of new capabilities and enhancements aimed at improving the efficiency,...
Webinar Modality Agnostic Drug Discovery Strategies for Data Sparse TargetsThis webinar in collaboration with Avammune, focuses on pursuing novel drug discovery targets with sparse or fragmented data...